{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:54:53Z","timestamp":1790520893550,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.neurol.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T16:24:25Z","timestamp":1508775865000},"page":"572-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["How to use stem cells for repair in stroke patients"],"prefix":"10.1016","volume":"173","author":[{"given":"O.","family":"Detante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Papassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2017.09.003_bib0255","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neurol.2014.10.005","article-title":"Biotherapies in stroke","volume":"170","author":"Detante","year":"2014","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0260","first-page":"861","article-title":"Plasticity during stroke recovery: from synapse to behaviour. Nature reviews","volume":"10","author":"Murphy","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2017.09.003_bib0265","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ana.20845","article-title":"Cellular and molecular mechanisms of neural repair after stroke: making waves","volume":"59","author":"Carmichael","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0270","doi-asserted-by":"crossref","first-page":"13198","DOI":"10.1073\/pnas.0603512103","article-title":"Evidence for stroke-induced neurogenesis in the human brain","volume":"103","author":"Jin","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2017.09.003_bib0275","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1523\/JNEUROSCI.4323-06.2006","article-title":"A neurovascular niche for neurogenesis after stroke","volume":"26","author":"Ohab","year":"2006","journal-title":"J Neurosc"},{"key":"10.1016\/j.neurol.2017.09.003_bib0280","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1161\/STROKEAHA.107.488445","article-title":"Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke","volume":"38","author":"Thored","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2017.09.003_bib0285","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.jcbfm.9600573","article-title":"Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke","volume":"28","author":"Teng","year":"2008","journal-title":"J Cereb blood flow Metab"},{"key":"10.1016\/j.neurol.2017.09.003_bib0290","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1073\/pnas.1016650108","article-title":"Astroglial networks scale synaptic activity and plasticity","volume":"108","author":"Pannasch","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2017.09.003_bib0295","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/glia.22320","article-title":"Crosstalk between oligodendrocytes and cerebral endothelium contributes to vascular remodeling after white matter injury","volume":"60","author":"Pham","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.neurol.2017.09.003_bib0300","doi-asserted-by":"crossref","first-page":"e8101","DOI":"10.1371\/journal.pone.0008101","article-title":"Microglial involvement in neuroplastic changes following focal brain ischemia in rats","volume":"4","author":"Madinier","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/j.neurol.2017.09.003_bib0305","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (masters): A randomised, double blind, placebo-controlled, phase 2\u00a0trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(16)30513-X","article-title":"Human neural stem cells in patients with chronic ischaemic stroke (pisces): a phase 1, first-in-man study","volume":"388","author":"Kalladka","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2017.09.003_bib0315","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jnr.22614","article-title":"Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke","volume":"89","author":"Yang","year":"2011","journal-title":"Journal of neuroscience research"},{"key":"10.1016\/j.neurol.2017.09.003_bib0320","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/jcbfm.2009.198","article-title":"Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats","volume":"30","author":"Brenneman","year":"2010","journal-title":"J Cereb blood flow Metab"},{"key":"10.1016\/j.neurol.2017.09.003_bib0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.jcbfm.9600311","article-title":"Therapeutic benefit of bone marrow stromal cells administered 1\u00a0month after stroke","volume":"27","author":"Shen","year":"2007","journal-title":"J Cereb blood flow Metab"},{"key":"10.1016\/j.neurol.2017.09.003_bib0330","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1007\/s00018-013-1290-8","article-title":"Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?","volume":"70","author":"Teixeira","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.neurol.2017.09.003_bib0335","doi-asserted-by":"crossref","first-page":"e72604","DOI":"10.1371\/journal.pone.0072604","article-title":"Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis and angiogenesis","volume":"8","author":"Hsieh","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.neurol.2017.09.003_bib0340","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3727\/096368916X691132","article-title":"Intravenous injection of clinical grade human mscs after experimental stroke: functional benefit and microvascular effect","volume":"25","author":"Moisan","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neurol.2017.09.003_bib0345","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.expneurol.2005.11.029","article-title":"Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats","volume":"198","author":"Li","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0350","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3727\/096368911X637380","article-title":"Neuroprotective effect of human placenta-derived cell treatment of stroke in rats","volume":"22","author":"Chen","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neurol.2017.09.003_bib0355","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.nbd.2010.12.009","article-title":"Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and il-5","volume":"41","author":"Sheikh","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2017.09.003_bib0360","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.20126","article-title":"Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells","volume":"49","author":"Li","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.neurol.2017.09.003_bib0365","doi-asserted-by":"crossref","first-page":"14638","DOI":"10.1073\/pnas.0803670105","article-title":"Stem\/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory\/immune responses","volume":"105","author":"Ohtaki","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2017.09.003_bib0370","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/brain\/awm306","article-title":"Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke","volume":"131","author":"Lee","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2017.09.003_bib0375","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-013-9492-x","article-title":"The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke","author":"Ge","year":"2014","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.neurol.2017.09.003_bib0380","doi-asserted-by":"crossref","first-page":"40758","DOI":"10.1038\/srep40758","article-title":"Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia","volume":"7","author":"Argibay","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2017.09.003_bib0385","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/FOC\/2008\/24\/3-4\/E14","article-title":"Intravascular cell replacement therapy for stroke","volume":"24","author":"Guzman","year":"2008","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.neurol.2017.09.003_bib0390","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/STROKEAHA.111.637884","article-title":"Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation","volume":"43","author":"Rosenblum","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2017.09.003_bib0395","doi-asserted-by":"crossref","DOI":"10.1111\/cns.12216","article-title":"Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke","author":"Wang","year":"2014","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neurol.2017.09.003_bib0400","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainres.2010.04.006","article-title":"Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia","volume":"1334","author":"Komatsu","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2017.09.003_bib0405","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(98)85026-5","article-title":"First cell transplant aimed to reverse stroke damage","volume":"352","author":"Bonn","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2017.09.003_bib0410","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2017.09.003_bib0415","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","article-title":"Neurotransplantation for patients with subcortical motor stroke: a phase 2\u00a0randomized trial","volume":"103","author":"Kondziolka","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1016\/j.neurol.2017.09.003_bib0420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000086518","article-title":"Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study","volume":"20","author":"Savitz","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.neurol.2017.09.003_bib0425","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10517-005-0229-y","article-title":"Cell therapy of brain stroke","volume":"139","author":"Rabinovich","year":"2005","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.neurol.2017.09.003_bib0430","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ana.20501","article-title":"Autologous mesenchymal stem cell transplantation in stroke patients","volume":"57","author":"Bang","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0435","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awr063","article-title":"Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke","volume":"134","author":"Honmou","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2017.09.003_bib0440","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.430","article-title":"A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cell"},{"key":"10.1016\/j.neurol.2017.09.003_bib0445","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000333381","article-title":"Autologous mesenchymal stem cells in chronic stroke","volume":"1","author":"Bhasin","year":"2011","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.neurol.2017.09.003_bib0450","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.clineuro.2012.10.015","article-title":"Stem cell therapy: a clinical trial of stroke","volume":"115","author":"Bhasin","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.neurol.2017.09.003_bib0455","first-page":"151","article-title":"Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study","volume":"27","author":"Su\u00e1rez-Monteagudo","year":"2009","journal-title":"Restor Neurol Neurosc"},{"key":"10.1016\/j.neurol.2017.09.003_bib0460","first-page":"52","article-title":"Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke","volume":"86","author":"Mendonca MLFd","year":"2006","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/rme.10.97","article-title":"Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke","volume":"6","author":"Battistella","year":"2011","journal-title":"Regen Med"},{"key":"10.1016\/j.neurol.2017.09.003_bib0470","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1161\/STROKEAHA.112.659409","article-title":"Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial","volume":"43","author":"Moniche","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2017.09.003_bib0475","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3727\/096368912X612512","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke","volume":"1","author":"Friedrich","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.neurol.2017.09.003_bib0480","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.22458","article-title":"Intravenous autologous bone marrow mononuclear cells for ischemic stroke","volume":"70","author":"Savitz","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2017.09.003_bib0485","first-page":"221","article-title":"Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: a pilot study","volume":"136","author":"Prasad","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.neurol.2017.09.003_bib0490","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1161\/STROKEAHA.114.007028","article-title":"Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial","volume":"45","author":"Prasad","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2017.09.003_bib0505","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1747493017696098","article-title":"Controlled clinical trials of cell therapy in stroke: Meta-analysis at six months after treatment","volume":"12","author":"Detante","year":"2017","journal-title":"Int J Stroke"},{"key":"10.1016\/j.neurol.2017.09.003_bib0495","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.116.012995","article-title":"Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1\/2a study","author":"Steinberg","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.neurol.2017.09.003_bib0500","doi-asserted-by":"crossref","first-page":"6810562","DOI":"10.1155\/2016\/6810562","article-title":"Biomaterial applications in cell-based therapy in experimental stroke","volume":"2016","author":"Boisserand","year":"2016","journal-title":"Stem Cell Int"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378717307282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378717307282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:37:58Z","timestamp":1750959478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378717307282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0035378717307282"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2017.09.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to use stem cells for repair in stroke patients","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}